Overall, 52.7% diabetics were diagnosed with NAFLD, while 20.9% diabetics were carriers of PNPLA3 genotype GG, 16.3% of CG, and 62.8% of CC. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.